Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Richtig, G; Hoeller, C; Kashofer, K; Aigelsreiter, A; Heinemann, A; Kwong, LN; Pichler, M; Richtig, E.
Beyond the BRAF(V)(600E) hotspot - Biology and clinical implications of rare BRAF gene mutations in melanoma patients.
Br J Dermatol. 2017;
PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Aigelsreiter Ariane
Heinemann Akos
Kashofer Karl
Pichler Martin
Richtig Erika
Richtig Georg

BRAF mutations can be found in approximately 50% of melanomas, whereas the most common BRAF mutation is the substitution of a valine residue at codon 600 to glutamic acid. BRAF(V)(600E) occurs in up to 95% of all melanoma cases and can be successfully blocked by using a combination of BRAF- and MEK-inhibitors. Due to the wider availability of next-generation sequencing, more non-V600 BRAF mutations are emerging, and the clinical implications of these mutations are widely unknown. In this review, we will discuss the biology of the MAPK-pathway and its different types of BRAF mutations as well as their effect on MEK activation. Current literature will be reviewed including in-vitro data, case reports and case series. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

© Meduni Graz Impressum